{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:27:33Z","timestamp":1786123653493,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["F30HD113414"],"award-info":[{"award-number":["F30HD113414"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32GM008042"],"award-info":[{"award-number":["T32GM008042"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32GM152342"],"award-info":[{"award-number":["T32GM152342"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bone.2026.117976","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:17:05Z","timestamp":1781309825000},"page":"117976","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PTH treatment is effective in the Aga2\/+ mouse model of moderate to severe osteogenesis imperfecta"],"prefix":"10.1016","volume":"211","author":[{"given":"Alexander","family":"Kot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davis","family":"Wachtell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Wight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roya","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Zieba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Krakow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2026.117976_bb0005","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","article-title":"Osteogenesis imperfecta","volume":"363","author":"Rauch","year":"2004","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.bone.2026.117976_bb0010","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrendo.2011.81","article-title":"New perspectives on osteogenesis imperfecta","volume":"7","author":"Forlino","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bone.2026.117976_bb0015","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.matbio.2018.03.010","article-title":"Osteogenesis imperfecta and therapeutics","volume":"71\u201372","author":"Morello","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.bone.2026.117976_bb0020","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/jbmr.4011","article-title":"Homozygous loss-of-function mutations in CCDC134 are responsible for a severe form of osteogenesis imperfecta","volume":"35","author":"Dubail","year":"2020","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.117976_bb0025","first-page":"799","article-title":"Premature chain termination is a unifying mechanism for COL1A1 null alleles in osteogenesis imperfecta type I cell strains","volume":"59","author":"Willing","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bone.2026.117976_bb0030","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.049398","article-title":"Dissecting the phenotypic variability of osteogenesis imperfecta","volume":"15","author":"Garibaldi","year":"2022","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bone.2026.117976_bb0035","article-title":"Bisphosphonate therapy for osteogenesis imperfecta","volume":"10","author":"Dwan","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bone.2026.117976_bb0040","article-title":"Long-term effects of bisphosphonate therapy: perforations, microcracks and mechanical properties","volume":"7","author":"Ma","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bone.2026.117976_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2019.00924","article-title":"Management of osteogenesis imperfecta","volume":"10","author":"Ralston","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bone.2026.117976_bb0050","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S8756-3282(01)00485-9","article-title":"Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women","volume":"29","author":"Roschger","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.bone.2026.117976_bb0055","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S8756-3282(00)00376-8","article-title":"Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women","volume":"27","author":"Boivin","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.bone.2026.117976_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115518","article-title":"Fifty years of bisphosphonates: what are their mechanical effects on bone?","volume":"138","author":"Burr","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.bone.2026.117976_bb0065","first-page":"801","article-title":"Catabolic and anabolic actions of parathyroid hormone on the skeleton","volume":"34","author":"Silva","year":"2011","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.bone.2026.117976_bb0070","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nrendo.2015.139","article-title":"PTH receptor-1 signalling\u2014mechanistic insights and therapeutic prospects","volume":"11","author":"Cheloha","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bone.2026.117976_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.833221","article-title":"PTH1R actions on bone using the cAMP\/protein kinase a pathway","volume":"12","author":"Martin","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bone.2026.117976_bb0080","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1210\/endo.138.11.5505","article-title":"The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats","volume":"138","author":"Dobnig","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2026.117976_bb0085","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1172\/JCI71101","article-title":"Evaluation of teriparatide treatment in adults with osteogenesis imperfecta","volume":"124","author":"Orwoll","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2026.117976_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.0040007","article-title":"ER stress-mediated apoptosis in a new mouse model of osteogenesis imperfecta","volume":"4","author":"Lisse","year":"2008","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bone.2026.117976_bb0095","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/jbmr.2824","article-title":"Osteoblast malfunction caused by cell stress response to procollagen misfolding in \u03b12(I)-G610C mouse model of osteogenesis imperfecta","volume":"31","author":"Mirigian","year":"2016","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.117976_bb0100","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.bbadis.2018.02.002","article-title":"4-PBA ameliorates cellular homeostasis in fibroblasts from osteogenesis imperfecta patients by enhancing autophagy and stimulating protein secretion","volume":"1864","author":"Besio","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.bone.2026.117976_bb0105","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/ncb2022","article-title":"TGF-\u03b2 type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling","volume":"12","author":"Qiu","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bone.2026.117976_bb0110","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nm.3544","article-title":"Excessive TGF\u03b2 signaling is a common mechanism in osteogenesis imperfecta","volume":"20","author":"Grafe","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2026.117976_bb0115","doi-asserted-by":"crossref","DOI":"10.1172\/JCI152571","article-title":"Targeting TGF-\u03b2 for treatment of osteogenesis imperfecta","volume":"132","author":"Song","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2026.117976_bb0120","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1210\/clinem\/dgad035","article-title":"Approach to the patient: pharmacological therapies for fracture risk reduction in adults with osteogenesis imperfecta","volume":"108","author":"Liu","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2026.117976_bb0125","first-page":"1076","article-title":"TGF-beta inhibition restores the responsiveness to osteoanabolic PTH treatment in the Crtap\u2212\/\u2212 model of recessive osteogenesis imperfecta","volume":"33","author":"Grafe","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.117976_bb0130","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00223-013-9770-2","article-title":"Teriparatide treatment in adult patients with osteogenesis imperfecta type I","volume":"93","author":"Gatti","year":"2013","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2026.117976_bb0135","doi-asserted-by":"crossref","first-page":"153","DOI":"10.11138\/ccmbm\/2017.14.1.153","article-title":"Efficacy of teriparatide vs neridronate in adults with osteogenesis imperfecta type I: a prospective randomized international clinical study","volume":"14","author":"Leali","year":"2017","journal-title":"Clin. Cases Miner. Bone Metab."},{"key":"10.1016\/j.bone.2026.117976_bb0140","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2026.6889","article-title":"Teriparatide plus zoledronic acid for osteogenesis imperfecta: a randomized clinical trial","author":"Hald","year":"2026","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2026.117976_bb0145","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro\u2013computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.117976_bb0150","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/jbmr.2539","article-title":"Establishing biomechanical mechanisms in mouse models: practical guidelines for systematically evaluating phenotypic changes in the diaphyses of long bones","volume":"30","author":"Jepsen","year":"2015","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.117976_bb0155","doi-asserted-by":"crossref","first-page":"E590","DOI":"10.1152\/ajpendo.00371.2018","article-title":"The PERK-EIF2\u03b1-ATF4 signaling branch regulates osteoblast differentiation and proliferation by PTH","volume":"316","author":"Zhang","year":"2019","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2026.117976_bb0160","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/jbmr.3095","article-title":"A chaperone complex formed by HSP47, FKBP65, and BiP modulates telopeptide lysyl hydroxylation of type I procollagen","volume":"32","author":"Duran","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.117976_bb0165","doi-asserted-by":"crossref","first-page":"34287","DOI":"10.1074\/jbc.M204973200","article-title":"An endoplasmic reticulum stress-specific caspase cascade in apoptosis: cytochrome c-independent activation of caspase-9 by caspase-12","volume":"277","author":"Morishima","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2026.117976_bb0170","doi-asserted-by":"crossref","first-page":"13935","DOI":"10.1074\/jbc.M010677200","article-title":"Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress","volume":"276","author":"Yoneda","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2026.117976_bb0175","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1196\/annals.1299.032","article-title":"Caspase-12 and ER-stress-mediated apoptosis: the story so far","volume":"1010","author":"Szegezdi","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bone.2026.117976_bb0180","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/sj.cdd.4401080","article-title":"Caspase-12 processing and fragment translocation into nuclei of tunicamycin-treated cells","volume":"9","author":"Fujita","year":"2002","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bone.2026.117976_bb0185","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1210\/en.2007-1573","article-title":"Parathyroid hormone increases activating transcription factor 4 expression and activity in osteoblasts: requirement for osteocalcin gene expression","volume":"149","author":"Yu","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2026.117976_bb0190","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.biochi.2018.12.006","article-title":"Parathyroid hormone-stimulation of Runx2 during osteoblast differentiation via the regulation of lnc-SUPT3H-1:16 (RUNX2-AS1:32) and miR-6797-5p","volume":"158","author":"Arumugam","year":"2019","journal-title":"Biochimie"},{"issue":"5","key":"10.1016\/j.bone.2026.117976_bb0195","article-title":"Regulation of osterix (Osx, Sp7) and the Osx promoter by parathyroid hormone in osteoblasts","volume":"43","year":"2009","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.bone.2026.117976_bb0200","doi-asserted-by":"crossref","first-page":"48868","DOI":"10.1074\/jbc.M208494200","article-title":"Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein","volume":"277","author":"Fu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2026.117976_bb0205","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5152\/eurasianjmed.2021.21197","article-title":"Parathyroid hormone on osteoprotegerin levels in patients with primary hyperparathyroidism","volume":"54","author":"Okudan","year":"2022","journal-title":"Eurasian J. Med."},{"key":"10.1016\/j.bone.2026.117976_bb0210","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1359\/JBMR.0301226","article-title":"PTH differentially regulates expression of RANKL and OPG","volume":"19","author":"Huang","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.117976_bb0215","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/jbmr.4389","article-title":"Anabolic actions of PTH in murine models: two decades of insights","volume":"36","author":"Zweifler","year":"2021","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.117976_bb0220","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/jbmr.4728","article-title":"PTH treatment increases cortical bone mass more in response to compression than tension in mice","volume":"38","author":"Rooney","year":"2023","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.117976_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2024.104926","article-title":"Imaging in osteogenesis imperfecta: where we are and where we are going","volume":"68","author":"Gazzotti","year":"2024","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.bone.2026.117976_bb0230","first-page":"53","article-title":"PTH and interactions with bisphosphonates","volume":"1","author":"Gasser","year":"2000","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"10.1016\/j.bone.2026.117976_bb0235","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa031975","article-title":"The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis","volume":"349","author":"Black","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2026.117976_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.607017","article-title":"Combination therapy of PTH and antiresorptive drugs on osteoporosis: a review of treatment alternatives","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bone.2026.117976_bb0245","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/jbmr\/zjae119","article-title":"Goal-directed osteoporosis treatment: ASBMR\/BHOF task force position statement 2024","volume":"39","author":"Cosman","year":"2024","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.117976_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/GL-2020-0524SUPPL","article-title":"American Association of Clinical Endocrinologists\/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis\u20142020 update","volume":"26","author":"Camacho","year":"2020","journal-title":"Endocr. Pract."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226002024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226002024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:44:41Z","timestamp":1786117481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328226002024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":50,"alternative-id":["S8756328226002024"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2026.117976","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PTH treatment is effective in the Aga2\/+ mouse model of moderate to severe osteogenesis imperfecta","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2026.117976","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117976"}}